Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

HTG Molecular Diagnostics Q1 EPS $(2.28) Misses $(1.94) Estimate, Sales $1.03M Miss $1.60M Estimate

Author: Michael Horton | May 10, 2023 05:28pm
HTG Molecular Diagnostics (NASDAQ:HTGM) reported quarterly losses of $(2.28) per share which missed the analyst consensus estimate of $(1.94) by 17.53 percent. This is a 76.54 percent increase over losses of $(9.72) per share from the same period last year. The company reported quarterly sales of $1.03 million which missed the analyst consensus estimate of $1.60 million by 35.50 percent. This is a 12.84 percent decrease over sales of $1.18 million the same period last year.

Posted In: HTGM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist